The medicines regulator has equipped investigators with intelligence software capable of dark-web searches, AI-driven analysis and ‘secure persona-based investigations’ as it steps up surveillance of illegal therapeutic goods sold and promoted online.
The medicines regulator has equipped investigators with intelligence software capable of dark-web searches, AI-driven analysis and ‘secure persona-based investigations’ as it steps up surveillance of illegal therapeutic goods sold and promoted online.
This content is for paid subscribers only.
Start your free trial nowor purchase a monthly or annual subscription to read.